Our Clinical Trials

register-1
Apply for future trials.
Paratus Clinical is always in need of dedicated patients who would like to contribute to answering important research questions.
If you would like to be contacted about future research opportunities, please select 'Register Now' and submit your details.
You will be contacted by a recruitment specialist shortly.

COVID-19 Influenza Combination Vaccine Study

A Phase 3 study to test the effectiveness of an investigational Novavax vaccine which aims to combine protection against COVID-19 and influenza in the one vaccine.

This study is being conducted at our Western Sydney, Brisbane, Central Coast and Canberra sities.

Apply Now
Placeholder Image

A Clinical Trial Investigating a Potential Dual Acting Weight Loss and Type 2 Diabetes Treatment

A Phase 3 Clinical Trial Comparing the Effectiveness of a New Investigational Treatment with Tirzepatide in Managing Type 2 Diabetes Glycaemic Control and Weight Reduction.

This study is being conducted at our Western Sydney and Canberra sites.

Apply Now
Placeholder Image

Cardiovascular and Lipoprotein (a) Study

The study is examining if lowering Lipoprotein (a), a type of cholesterol, can reduce the risk of cardiovascular events. If you have known cardiovascular disease or are at risk of cardiovascular disease (including a family history), you might be eligible for this 4-year study. See below for more details.

This study is being conducted at our at our Western Sydney, Central Coast, Canberra, and Brisbane sites.

Apply Now
Placeholder Image

Investigational Weight Loss Injectable Treatment Study at Paratus Clinical

A 51-week, placebo-controlled study evaluating the effectiveness of different dosages of a new investigational weight loss injectable treatment.

This study is being conducted at our Western Sydney, Central Coast and Brisbane sites.

Apply Now
Placeholder Image
1 2 3 4